Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_assertion type Assertion NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_head.
- NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_assertion description "[Assessment of MYC mRNA levels is feasible and may be incorporated in prospective PNET/MB clinical trials to aid in treatment planning for patients with PNET/MB on confirmation of our results in larger studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_provenance.
- NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_assertion evidence source_evidence_literature NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_provenance.
- NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_assertion SIO_000772 11489822 NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_provenance.
- NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_assertion wasDerivedFrom befree-2016 NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_provenance.
- NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_assertion wasGeneratedBy ECO_0000203 NP326210.RAPvk0tpI53aTa5RH08XEpWYg0LZlMl8XG-vbxUa-9OQo130_provenance.